| Local Ca2+ detection and modulation of synaptic release by astrocytes MA Di Castro, J Chuquet, N Liaudet, K Bhaukaurally, M Santello, ... Nature neuroscience 14 (10), 1276-1284, 2011 | 585 | 2011 |
| Potential mechanisms of interleukin-1 involvement in cerebral ischaemia O Touzani, H Boutin, J Chuquet, N Rothwell Journal of neuroimmunology 100 (1-2), 203-215, 1999 | 368 | 1999 |
| Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex J Chuquet, P Quilichini, EA Nimchinsky, G Buzsáki Journal of Neuroscience 30 (45), 15298-15303, 2010 | 255 | 2010 |
| High-resolution in vivo imaging of the neurovascular unit during spreading depression J Chuquet, L Hollender, EA Nimchinsky Journal of Neuroscience 27 (15), 4036-4044, 2007 | 248 | 2007 |
| Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor–related protein-mediated transcytosis K Benchenane, V Berezowski, C Ali, M Fernández-Monreal, ... Circulation 111 (17), 2241-2249, 2005 | 225 | 2005 |
| Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat J Chuquet, K Benchenane, J Toutain, ET MacKenzie, S Roussel, ... Stroke 33 (12), 3019-3025, 2002 | 71 | 2002 |
| Endozepines and their receptors: structure, functions and pathophysiological significance MC Tonon, H Vaudry, J Chuquet, F Guillebaud, J Fan, O Masmoudi-Kouki, ... Pharmacology & therapeutics 208, 107386, 2020 | 69 | 2020 |
| Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-β3-pseudopeptide Agonist C Neveu, B Lefranc, O Tasseau, JC Do-Rego, A Bourmaud, P Chan, ... Journal of Medicinal Chemistry 55 (17), 7516-7524, 2012 | 35 | 2012 |
| Spontaneously hypertensive rats are highly vulnerable to AMPA-induced brain lesions C Lecrux, O Nicole, L Chazalviel, C Catone, J Chuquet, ET MacKenzie, ... Stroke 38 (11), 3007-3015, 2007 | 25 | 2007 |
| Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson’s disease S Bahdoudi, I Ghouili, M Hmiden, JL Do Rego, B Lefranc, J Leprince, ... Cellular and Molecular Life Sciences 75, 2075-2091, 2018 | 17 | 2018 |
| Molecular basis of agonist docking in a human GPR 103 homology model by site‐directed mutagenesis and structure–activity relationship studies C Neveu, F Dulin, B Lefranc, L Galas, C Calbrix, R Bureau, S Rault, ... British Journal of Pharmacology 171 (19), 4425-4439, 2014 | 17 | 2014 |
| Vascular response to spreading depolarization predicts stroke outcome NF Binder, C Glück, W Middleham, M Alasoadura, N Pranculeviciute, ... Stroke 53 (4), 1386-1395, 2022 | 16 | 2022 |
| Effects of urotensin-II on cerebral blood flow and ischemia in anesthetized rats J Chuquet, C Lecrux, D Chatenet, J Leprince, L Chazalviel, S Roussel, ... Experimental neurology 210 (2), 577-584, 2008 | 16 | 2008 |
| The gliopeptide ODN, a ligand for the benzodiazepine site of GABAA receptors, boosts functional recovery after stroke R Lamtahri, M Hazime, EK Gowing, RY Nagaraja, J Maucotel, ... Journal of Neuroscience 41 (33), 7148-7159, 2021 | 13 | 2021 |
| Prolonged deficit of low gamma oscillations in the peri-infarct cortex of mice after stroke M Hazime, M Alasoadura, R Lamtahri, P Quilichini, J Leprince, D Vaudry, ... Experimental Neurology 341, 113696, 2021 | 13 | 2021 |
| Detection, characterization and biological activities of [bisphospho-thr3, 9] ODN, an endogenous molecular form of ODN released by astrocytes K Gach, O Belkacemi, B Lefranc, P Perlikowski, J Masson, ... Neuroscience 290, 472-484, 2015 | 11 | 2015 |
| Design, synthesis, molecular dynamics simulation, and functional evaluation of a novel series of 26RFa peptide analogues containing a mono-or polyalkyl guanidino arginine … K Alim, B Lefranc, J Sopkova-de Oliveira Santos, C Dubessy, M Picot, ... Journal of Medicinal Chemistry 61 (22), 10185-10197, 2018 | 8 | 2018 |
| Matching gene expression with hypometabolism after cerebral ischemia in the nonhuman primate J Chuquet, K Benchenane, G Liot, M Fernández-Monreal, J Toutain, ... Journal of Cerebral Blood Flow & Metabolism 22 (10), 1165-1169, 2002 | 8 | 2002 |
| Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases O Masmoudi-Kouki, A Namsi, Y Hamdi, S Bahdoudi, I Ghouili, J Chuquet, ... Frontiers in Endocrinology 11, 566026, 2020 | 7 | 2020 |
| Point-substitution of phenylalanine residues of 26RFa neuropeptide: a structure-activity relationship study B Lefranc, K Alim, C Neveu, O Le Marec, C Dubessy, JA Boutin, ... Molecules 26 (14), 4312, 2021 | 4 | 2021 |
David VaudryChercheur INSERM, Unité INSERM 982, Plates-Formes PRIMACEN et PISSARO, Université de RouenAdresse e-mail validée de univ-rouen.fr
